TITAN MEDICAL INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.055 CAD | 0.00% |
|
0.00% | -31.25% |
| Apr. 22 | Titan Medical Provides Update on Merger with Conavi | MT |
| Apr. 22 | Titan Medical Brief: Providing Update on Planned Merger with Conavi | MT |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 26.82 | 19.47 | 140 | 72.07 | 74.27 | 6.87 |
| Enterprise Value (EV) 1 | 15.35 | 18.68 | 117.3 | 41.09 | 72.69 | 0.6031 |
| P/E ratio | -0.91 x | -0.37 x | -4.72 x | -4.63 x | -1.74 x | 1.01 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | - | - | 7,000,780 x | 3,586,848 x | - | 389,636 x |
| EV / Revenue | - | - | 5,867,443 x | 2,045,067 x | - | 34,203 x |
| EV / EBITDA | -0.39 x | -0.32 x | 27.1 x | -1.37 x | -1.65 x | 0.06 x |
| EV / FCF | -0.47 x | -0.61 x | 4.2 x | -0.74 x | -4.42 x | 0.34 x |
| FCF Yield | -212% | -163% | 23.8% | -134% | -22.6% | 296% |
| Price to Book | 6.36 x | -1.71 x | -10.3 x | 2.04 x | -23.5 x | 1.44 x |
| Nbr of stocks (in thousands) | 21,676 | 38,935 | 82,185 | 111,128 | 111,891 | 113,848 |
| Reference price 2 | 1.237 | 0.5000 | 1.704 | 0.6485 | 0.6638 | 0.0603 |
| Announcement Date | 2/13/19 | 3/30/20 | 2/22/21 | 3/24/22 | 5/31/23 | 4/1/24 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales | - | - | 20 | 20.09 | - | 17.63 |
| EBITDA 1 | -39.66 | -59.24 | 4.329 | -29.91 | -44.03 | 10.54 |
| EBIT 1 | -39.69 | -59.27 | 4.197 | -30.31 | -44.49 | 10.36 |
| Operating Margin | - | - | 20.98% | -150.84% | - | 58.73% |
| Earnings before Tax (EBT) 1 | -22.64 | -41.91 | -24.18 | -14.8 | -42.6 | 6.977 |
| Net income 1 | -22.64 | -41.91 | -24.18 | -14.86 | -42.54 | 6.953 |
| Net margin | - | - | -120.92% | -73.95% | - | 39.43% |
| EPS 2 | -1.361 | -1.366 | -0.3609 | -0.1400 | -0.3815 | 0.0600 |
| Free Cash Flow 1 | -32.5 | -30.41 | 27.94 | -55.22 | -16.44 | 1.787 |
| FCF margin | - | - | 139.71% | -274.81% | - | 10.13% |
| FCF Conversion (EBITDA) | - | - | 645.55% | - | - | 16.95% |
| FCF Conversion (Net income) | - | - | - | - | - | 25.7% |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 2/13/19 | 3/30/20 | 2/22/21 | 3/24/22 | 5/31/23 | 4/1/24 |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 |
|---|---|---|---|
| Net sales 1 | - | 12.56 | - |
| EBITDA | - | - | - |
| EBIT 1 | -17.57 | -3.876 | -15.78 |
| Operating Margin | - | -30.85% | - |
| Earnings before Tax (EBT) 1 | - | - | -12.01 |
| Net income 1 | - | - | -12.01 |
| Net margin | - | - | - |
| EPS 2 | - | - | -0.1042 |
| Dividend per Share | - | - | - |
| Announcement Date | 11/11/21 | 3/24/22 | 5/12/22 |
1CAD in Million2CAD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 11.5 | 0.79 | 22.7 | 31 | 1.58 | 6.27 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | -32.5 | -30.4 | 27.9 | -55.2 | -16.4 | 1.79 |
| ROE (net income / shareholders' equity) | -328% | 1,123% | 190% | -138% | -265% | 858% |
| ROA (Net income/ Total Assets) | -96.2% | -293% | 15.8% | -49.2% | -102% | 81.5% |
| Assets 1 | 23.54 | 14.31 | -153.1 | 30.22 | 41.57 | 8.531 |
| Book Value Per Share 2 | 0.1900 | -0.2900 | -0.1700 | 0.3200 | -0.0300 | 0.0400 |
| Cash Flow per Share 2 | 0.5300 | 0.0200 | 0.3100 | 0.2900 | 0.0300 | 0.0700 |
| Capex | - | - | 0.28 | 0.37 | 0.7 | - |
| Capex / Sales | - | - | 1.4% | 1.84% | - | - |
| Announcement Date | 2/13/19 | 3/30/20 | 2/22/21 | 3/24/22 | 5/31/23 | 4/1/24 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -31.25% | 4.58M | |
| +8.07% | 219B | |
| +6.59% | 183B | |
| +11.26% | 133B | |
| +26.57% | 108B | |
| +0.65% | 63.06B | |
| +13.35% | 52.02B | |
| -0.62% | 48.2B | |
| -0.93% | 40.37B | |
| +11.54% | 39.35B |
- Stock Market
- Equities
- TMD Stock
- Financials Titan Medical Inc.
